The invention relates to novel compounds having the general formula: (1) wherein X is O or S which are useful as selective ER-β ligands in the treatment or prophylaxis of Alzheimer's disease, anxiety disorders, depressive disorders, osteoporosis, cardiovascular disease, rheumatoid arthritis or prostate cancer. 展开▼
机译：本发明涉及具有以下通式的新型化合物：（1）其中X是O或S，其用作治疗或预防阿尔茨海默氏病，焦虑症，抑郁症，骨质疏松症，心血管疾病，类风湿病的选择性ER-β配体关节炎或前列腺癌。 <图像alt =“嵌入式图像” file =“ US20060106074A1-20060518-C00001.GIF” he =“ 27.35mm” imgContent =“ chem” imgFormat =“ GIF” wi =“ 55.46mm“ />
展开▼
